Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
Protein arginine methyltransferase (PRMT) 5 is over-expressed in a variety of cancers and the master transcription regulator E2F1 is an important methylation target. We have explored the role of PRMT5 and E2F1 in regulating the non-coding genome and report here a striking effect on long non-coding (...
Príomhchruthaitheoirí: | Barczak, W, Carr, SM, Liu, G, Munro, S, Nicastri, A, Lee, LN, Hutchings, C, Ternette, N, Klenerman, P, Kanapin, A, Samsonova, A, La Thangue, NB |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Springer Nature
2023
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
de réir: Wojciech Barczak, et al.
Foilsithe / Cruthaithe: (2023-02-01) -
Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control
de réir: Roworth, A, et al.
Foilsithe / Cruthaithe: (2019) -
Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma
de réir: Bate‐Eya, LT, et al.
Foilsithe / Cruthaithe: (2024) -
Lysine methylation regulates the pRb tumour suppressor protein.
de réir: Munro, S, et al.
Foilsithe / Cruthaithe: (2010) -
Diversity within the pRb pathway: is there a code of conduct?
de réir: Munro, S, et al.
Foilsithe / Cruthaithe: (2012)